Supplemental material
Journal of Dermatological Treatment
Volume 35, 2024 - Issue 1
Research Article
Comparison between super-responders and non-super-responders in psoriasis under adalimumab treatment: a real-life cohort study on the effectiveness and drug survival over one-year
Yizhang Liua Department of Dermatology, Xiangya Hospital, Central South University, Changsha, China;b National Engineering Research Center of Personalized Diagnostic and Therapeutic Technology, Changsha, China;c Furong Laboratory, Changsha, China;d National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Changsha, China;e Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital, Changsha, China;f Hunan Engineering Research Center of Skin Health and Disease, Xiangya Hospital, Changsha, China;g Xiangya Clinical Research Center for Cancer Immunotherapy, Central South University, Changsha, China
https://orcid.org/0009-0001-0465-2829View further author information
https://orcid.org/0009-0001-0465-2829View further author information, Kun Hua Department of Dermatology, Xiangya Hospital, Central South University, Changsha, China;b National Engineering Research Center of Personalized Diagnostic and Therapeutic Technology, Changsha, China;c Furong Laboratory, Changsha, China;d National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Changsha, China;e Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital, Changsha, China;f Hunan Engineering Research Center of Skin Health and Disease, Xiangya Hospital, Changsha, China;g Xiangya Clinical Research Center for Cancer Immunotherapy, Central South University, Changsha, Chinahttps://orcid.org/0000-0001-9717-4012View further author information
https://orcid.org/0000-0001-9717-4012View further author information, Lu Jiana Department of Dermatology, Xiangya Hospital, Central South University, Changsha, China;b National Engineering Research Center of Personalized Diagnostic and Therapeutic Technology, Changsha, China;c Furong Laboratory, Changsha, China;d National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Changsha, China;e Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital, Changsha, China;f Hunan Engineering Research Center of Skin Health and Disease, Xiangya Hospital, Changsha, China;g Xiangya Clinical Research Center for Cancer Immunotherapy, Central South University, Changsha, Chinahttps://orcid.org/0000-0002-7701-3649View further author information
https://orcid.org/0000-0002-7701-3649View further author information, Yongfang Duana Department of Dermatology, Xiangya Hospital, Central South University, Changsha, China;b National Engineering Research Center of Personalized Diagnostic and Therapeutic Technology, Changsha, China;c Furong Laboratory, Changsha, China;d National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Changsha, China;e Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital, Changsha, China;f Hunan Engineering Research Center of Skin Health and Disease, Xiangya Hospital, Changsha, China;g Xiangya Clinical Research Center for Cancer Immunotherapy, Central South University, Changsha, Chinahttps://orcid.org/0009-0001-7502-2066View further author information
https://orcid.org/0009-0001-7502-2066View further author information, Mi Zhanga Department of Dermatology, Xiangya Hospital, Central South University, Changsha, China;b National Engineering Research Center of Personalized Diagnostic and Therapeutic Technology, Changsha, China;c Furong Laboratory, Changsha, China;d National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Changsha, China;e Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital, Changsha, China;f Hunan Engineering Research Center of Skin Health and Disease, Xiangya Hospital, Changsha, China;g Xiangya Clinical Research Center for Cancer Immunotherapy, Central South University, Changsha, ChinaCorrespondence[email protected]
https://orcid.org/0000-0001-6795-0076View further author information
https://orcid.org/0000-0001-6795-0076View further author information & Yehong Kuanga Department of Dermatology, Xiangya Hospital, Central South University, Changsha, China;b National Engineering Research Center of Personalized Diagnostic and Therapeutic Technology, Changsha, China;c Furong Laboratory, Changsha, China;d National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Changsha, China;e Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital, Changsha, China;f Hunan Engineering Research Center of Skin Health and Disease, Xiangya Hospital, Changsha, China;g Xiangya Clinical Research Center for Cancer Immunotherapy, Central South University, Changsha, ChinaCorrespondence[email protected]
https://orcid.org/0000-0002-1133-1791View further author information
https://orcid.org/0000-0002-1133-1791View further author information